Videonystagmography as a tool to assess blepharospasm before and after botulinum toxin injection
- PMID: 18581129
- DOI: 10.1007/s00417-008-0877-5
Videonystagmography as a tool to assess blepharospasm before and after botulinum toxin injection
Abstract
Background: The aim of this paper was to study blinking parameters using a videonystagmography device, in order to objectively determine disability, and to assess the efficiency of botulinum toxin injection in patients with essential blepharospasm.
Methods: Blinking was studied using the features of pupillary occlusion (PO) as recorded on a videonystagmography device. In 23 patients presenting with essential blepharospasm, we studied the frequency, the percentage, the mean duration of PO, and the longest PO in a 5-minute test period. Patients were tested prior to botulinum toxin injection, and 1 month and 3 months after injection, respectively. PO levels lower than 0.3 s and higher than 0.3 s were studied separately.
Results: At 1 month after injection, botulinum toxin significantly influenced PO higher than 0.3 s, both in frequency (9.6/min +/- 8.2 on Day 0 and 4.7/min +/- 7.2 at Month 1; p = 0.004), and in mean duration (0.95 s +/- 0.84 on Day 0 and 0.58 s +/- 0.34 at Month 1; p = 0.03). On the other hand, we found no significant effect on PO lower than 0.3 s, both in frequency (32.4/min +/- 28.4 on Day 0 and 31.3/min +/- 29.0 at Month 1; p = 0.7) and in mean duration (0.16 s +/- 0.04 on Day 0 and 0.15 s +/- 0.03 at Month 1; p = 0.04). Botulinum toxin also significantly influenced the mean duration of the longest PO (6.44 s +/- 9.4 on Day 0 and 1.55 s +/- 1.9 at Month 1; p = 0.004) as well as the percentage of PO (29.95% +/- 24.6 on Day 0 and 13.44% +/- 11.1 at Month 1; p = 0.003).
Conclusions: PO can be used as the indirect sign of blinking. Videonystagmography provides a real-time result, and could be used to objectively evaluate the effect of botulinum toxin treatment in essential blepharospasm patients.
Similar articles
-
Videonystagmography to assess eyelid dynamic disorders.Orbit. 2009;28(1):20-4. doi: 10.1080/01676830802541004. Orbit. 2009. PMID: 19229740
-
Ocular surface alterations in blepharospasm patients treated with botulinum toxin A injection.Eur J Ophthalmol. 2014 Nov-Dec;24(6):830-4. doi: 10.5301/ejo.5000482. Epub 2014 May 1. Eur J Ophthalmol. 2014. PMID: 24803156
-
Effects of Repeated Eyelid Injections with Botulinum Toxin A on Innervation of Treated Muscles in Patients with Blepharospasm.Curr Eye Res. 2019 Mar;44(3):257-263. doi: 10.1080/02713683.2018.1543707. Epub 2018 Nov 23. Curr Eye Res. 2019. PMID: 30380945 Free PMC article.
-
Treatment of hyperfunctional lines of the face with botulinum toxin A.Dermatol Surg. 1998 Nov;24(11):1198-205. doi: 10.1111/j.1524-4725.1998.tb04098.x. Dermatol Surg. 1998. PMID: 9834739 Review.
-
[Treatment of focal dystonia with botulinum toxin A].Wien Klin Wochenschr. 2001;113 Suppl 4:6-10. Wien Klin Wochenschr. 2001. PMID: 15506045 Review. German.
Cited by
-
Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm.J Neural Transm (Vienna). 2011 Jun;118(6):925-43. doi: 10.1007/s00702-010-0546-9. Epub 2011 Jan 9. J Neural Transm (Vienna). 2011. PMID: 21221669 Free PMC article. Review.
-
Quantitative evaluation of blinking in blepharospasm using electrooculogram-integrated smart eyeglasses.Sci Rep. 2023 Jun 18;13(1):9868. doi: 10.1038/s41598-023-36094-4. Sci Rep. 2023. PMID: 37332074 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical